5
MATTHEW B. STERN, MBA, CHFP, CRCR 1308 Veranda Way, Lancaster PA 17601 (Open to Extensive Travel) C: (717) 989-0580 O: (717) 431-5913 E: [email protected] Corporate Account Manager / Sales Management / Regional Reimbursement Manager / Access Account Management CORE COMPETENCIES Lead sales team Managed budgets across sales Region Motivated / Coached Representatives C-suite Relationship Building Effectiveness Expertise in Hospital / Institution / IDN Revenue Cycle Management Trade & Distribution Modeling (3PL) Lead & Developed Sales & Cross-Functional Teams (Team Build-Outs) New Product Launches Business / Sales Strategy Development National / Regional Account Management Cross Functionality Large Contract Negotiation / Clear "Value Proposition" to End User Buy & Bill / Reimbursement Implementation & Pull-through Strategy Advocacy Group / KOL Development Insights to MAC Determinations / Coverage Impact, Oncology CAC Relationships Managed Care Development & Training Data Analysis / ROI Analysis Commercial / Medicare / Medicaid Payer Experience Product Launch Tactics with Managed Care CHFP - Certified Healthcare Financial Professional Certification Tactical Planning & Execution PROFESSIONAL EXPERIENCE Dendreon Corp. Seattle WA / 2/2015 purchased by Valeant (08/14 – (Currently on payroll, - all insurances and commissions being paid in full / with Valeant as new ownership, CAM position has been eliminated as part of organization restructuring) Corporate Account Manager Mid-Atlantic Region (08/14 to 2015) Urology & Oncology Acted as player-coach: high-level reimbursement / access interface for Buy & Bill strategies / tactics building contracts and rebates. Lead a team of 4 territory representatives with in the Mid-Atlantic Region. Built business plans and implemented strategy and tactics. Buy & Bill reimbursement and contracting among Mid-Atlantic Oncology & Urology practices, for a $110,000 product/year Grew business in Key accounts 69.5% by end of 2014. Spectrum Pharmaceuticals Inc., Irvine CA (02/09 to 8/2014) Corporate Account Manager Northeast Region (01/14 to 8/2014) Focus Oncology GPOs and Mega Oncology practices for Buy & Bill / Infusible Oncology / Hematology products. Insights to Commercial regional payers, interfaced to diffuse reimbursement / access barriers. Region finished #1 in nation for all CAMs 2014. 131% to goal for IC for. Q1 and Q2 2014. Created and negotiated a National Fusilev Contract at CTCA and all sites of care. Implemented complete pull-through plan in concert with Med Assets GPO. Exceeded target goal by over 30,000 new vials of business, equates to $6.4MM of new revenues, initiated new corporate partnership for future endeavors. 1

Matthew Stern MResume PA Nov-9-2015

Embed Size (px)

Citation preview

Page 1: Matthew Stern MResume PA Nov-9-2015

MATTHEW B. STERN, MBA, CHFP, CRCR1308 Veranda Way, Lancaster PA 17601 (Open to Extensive Travel) C: (717) 989-0580 O: (717) 431-5913 E: [email protected]

Corporate Account Manager / Sales Management / Regional Reimbursement Manager / Access Account Management

CORE COMPETENCIES

• Lead sales team• Managed budgets across sales Region• Motivated / Coached Representatives • C-suite Relationship Building Effectiveness • Expertise in Hospital / Institution / IDN Revenue Cycle

Management • Trade & Distribution Modeling (3PL)• Lead & Developed Sales & Cross-Functional Teams (Team Build-

Outs) New Product Launches • Business / Sales Strategy Development• National / Regional Account Management Cross Functionality • Large Contract Negotiation / Clear "Value Proposition" to End

User

• Buy & Bill / Reimbursement Implementation & Pull-through Strategy

• Advocacy Group / KOL Development• Insights to MAC Determinations / Coverage Impact, Oncology

CAC Relationships • Managed Care Development & Training• Data Analysis / ROI Analysis • Commercial / Medicare / Medicaid Payer Experience • Product Launch Tactics with Managed Care• CHFP - Certified Healthcare Financial Professional Certification• Tactical Planning & Execution

PROFESSIONAL EXPERIENCEDendreon Corp. Seattle WA / 2/2015 purchased by Valeant (08/14 – (Currently on payroll, - all insurances and commissions being paid in full / with Valeant as new ownership, CAM position has been eliminated as part of organization restructuring)

Corporate Account Manager Mid-Atlantic Region (08/14 to 2015) Urology & Oncology• Acted as player-coach: high-level reimbursement / access interface for Buy & Bill strategies / tactics building contracts and rebates.• Lead a team of 4 territory representatives with in the Mid-Atlantic Region. Built business plans and implemented strategy and tactics. • Buy & Bill reimbursement and contracting among Mid-Atlantic Oncology & Urology practices, for a $110,000 product/year • Grew business in Key accounts 69.5% by end of 2014.

Spectrum Pharmaceuticals Inc., Irvine CA (02/09 to 8/2014)Corporate Account Manager Northeast Region (01/14 to 8/2014)

• Focus Oncology GPOs and Mega Oncology practices for Buy & Bill / Infusible Oncology / Hematology products. Insights to Commercial regional payers, interfaced to diffuse reimbursement / access barriers.

• Region finished #1 in nation for all CAMs 2014. 131% to goal for IC for. Q1 and Q2 2014.• Created and negotiated a National Fusilev Contract at CTCA and all sites of care. Implemented complete pull-through plan in concert with Med

Assets GPO. Exceeded target goal by over 30,000 new vials of business, equates to $6.4MM of new revenues, initiated new corporate partnership for future endeavors.

Integrated Health Systems Manager – Great Lakes and Mid-Atlantic Regions (01/13 to 12/13)• Lead a team of 4 IHS Managers. Tasked with placing products on formulary and resolving any reimbursement or coverage issues. Partnership

with sales to uncover opportunities and take on special projects/roles to help facilitate greater sales growth.• Created value proposition discussion across portfolio that deliver product pharmacoeconomic modeling. • Responsible for executive level strategic business development and product pull through within major hospital systems in MO, PA, OH, MI;

National/Regional MCOs: UPMC Health Care, Highmark, and Geisinger Health Care Plan, Keystone etc. • Targeted Hospital Systems: UPMC (PA), West Penn Allegheny Health System (PA), Geisinger Health System (PA), Henry Ford Health System

(Detroit), Trinity Health (Novi) Ascension Health (Saint Louis), Barnes Jewish HealthCare (Saint Louis) Cleveland Clinic Health System, Health Alliance of Greater Cincinnati, Jefferson Health System (PA), University of PA Health System, Aurora Health Care (Milwaukee) etc.

• Specialty GPO account relationships: ION, Med Assets, McKesson, McKesson Specialty, OnMark, Cardinal, Vital Source, Unity (US Oncology), Novation, Premier, The Broadlane Group, HealthTrust Purchasing Group, Consorta, HC Pharmacy (UPMC), Provider Supply Chain Partners, (Allegheny Health System) New GPO for Highmark

Regional Business Manager (Sales Manager) Mid-Atlantic and OH Valley Regions (06/10 to 01/13)• Lead a team of 8 Oncology Specialty Representatives, Buy & Bill strategies for oncologists in hospitals and physician offices. Well versed

with contracts and contract strategies with challenging products, executing all strategies and tactics within accounts / regions.• Performed coaching field visits with representatives, mentored, motivated, and guided team to meet and exceed national and regional goals.• Interviewed, hired, and recommended promotions for sales team while managing and evaluating ROI on promotional budgets. • Performed yearly performance evaluations for each team member while providing constructive feedback guiding representatives to achieve

personal goals.• Discussing value proposition across portfolio, delivers pharmacoeconomic modeling of products. Business analysis and strategic planning, new

site of care setup, key account management, reimbursement pull through, clinic/hospital product contracting, GPO, and government relations in PA, MO, OH, KY, IN, MI. Channel focus: Commercial MCOs, Managed Medicare, IDNs, ACOs etc.

• Key accounts: OHC, UPMC, West Penn Highmark etc.• Increased 2012 product sales in 75 of 79 accounts. Added 17 NEW accounts in Q3 2012, and 10 NEW accounts Q4 2012• Negotiated/implemented NEW Q3/Q4 Fusilev contract at OHC increased Fusilev sales from 3000 vials Q2 to 7000+vials for Q3 and Q4 for 2012.

1

Page 2: Matthew Stern MResume PA Nov-9-2015

Radio Immune Therapy Specialist - PA / NY / DE / MD (02/09 to 06/10)• 2nd Qtr. 2011 ranked 1th in US for volume of Zevalin sales; 2nd Qtr. 2011 171.4% of goal 2nd Qtr. 2011 200% increase from 1st Qtr. 2011 to

2nd Qtr. 2011. Finished 4th in United States with 178% growth year over year 2010 vs. 2009• Executive Task Force for the North East Region 2011• 2nd Qtr. 2010 Stock Option Contest Winner. 2nd Qtr. 2010 ranked #1 in NYC / Philly Metro Area for number of new revenue generating patients.

1st Qtr. 2010 Stock Option Contest Winner, 1st Qtr. 2010 ranked #5 US for number of new revenue generating patients• 4th Qtr. 2009 Stock Option Contest Winner. 3rd Qtr. YTD 2009 Ranked #4 in the United States for number of new revenue generating patients

Alexion Pharmaceuticals Inc., Cheshire, CT (01/07 to 2/09)Regional Account Manager - PA / NJ Region (01/07 to 2/09)

• Finished 2008 ranked #1 in the United States for number of new revenue generating patients• Finished 2008 ranked #1 in the East Area for number of new revenue generating patients• Second Quarter 2008 ranked #1 in the United States for number of new revenue generating patients• First and Second Quarters 2008 ranked #1 in US for number of new cases generated• April 2008, Won “Achieving More Faster” Award in Qtr. 1 2008• April 2008 ranked #1 in the East Area for number of new revenue generating patients• First RAM to have a commercial third party payer approve Soliris™ in the United States in March 2007• POHMS clinical and business liaison for Eastern Area• Lead East Area in converting patients in to revenue generating therapy • Currently have one of the highest patient retention rates of dose delivered on time with in the United States

Abraxis BioScience Inc., Los Angeles CA (03/04 to 01/07)Oncology Division, Mid-Atlantic RegionRegional Account Manager Mid-Atlantic Region (08/05 to 01/07)

• As of January 2007 Ranked 1st in the United States. Finished 2006 Ranked 1st in the United States• Currently UPMC is the top account with in the United States in terms of volume of Abraxane™ Sales• Abraxane™ Formulary approval at Johns Hopkins Medical Center April 2006 • Finished # 1 out of 10 RAMs nationally based on percentage of goal in 2005

Accounts: (List is Not all Inclusive)• Johns Hopkins Medical Center• University of Pennsylvania • Temple University • Thomas Jefferson University• Drexel Medical School• Cooper Hospital and Health System• Ohio State University Medical Center –

James Cancer Hospital

• Georgetown University – Lombardi Cancer Center

• University of Maryland• West Virginia University• Univ. of Pittsburgh Medical Center (UPMC)• The George Washington University• Andrews Air Force Base• Walter Reed Hospital

• University of Virginia• Hershey Medical Center• National Cancer Institute• MedStar Health, Inc.• Geisinger Health Systems• All IDNs in Mid-Atlantic Region • ION LPPs in the Mid-Atlantic Region• P 4 Large Accounts

Oncology Specialist (03/04 to 08/05)

Bristol-Myers Squibb Company, Princeton NJ (01/02 to 03/04)Oncology Division, Philadelphia-Baltimore District, Penn-Jersey District Management Candidate (2/01 to 3/04)Oncology Territory Business Manager (01/02 to 03/04)

• POHMS clinical and business liaison for BMSO • Ranked # 1 the Eastern Region, Paraplatin growth for Q1 2003. Ranked # 1 Eastern Region in Paraplatin and Taxol® growth for Q4 2003.

Ranked # 14 US Paraplatin growth for Q1 2003. 203.94% of territory goal for Q1 2003; 120.24% Q2 2003; 268.64% Q4 2003• Increased Paraplatin business $9,134,000 or +50.1% (over historical data) since taking over territory• 2003 YTD Paraplatin Growth 27.83%• Took territory from –72.4% YTD Taxol Growth (Sept. 2002) to (Dec. 2003) +21.2% YTD Taxol Growth• Took territory from –1.8% YTD Paraplatin® Growth (August 2002) to (Dec. 2002) +20.0% YTD Growth

Novartis Pharmaceuticals Corporation, East Hanover NJ (06/98 to 1/02)Senior Sales Consultant Specialist (1/02)Respiratory & Skin Disease Specialist (3/01 to 1/02)Baltimore Area D.P.M. Skills Trainer (12/01 to 01/02)Philadelphia Area Skills Trainer (3/01 to 12/01)Management Candidate (2/01 to present)Generates revenue from sales potential within territory through promotion of respiratory, allergy, pediatric, and dermatology products to key Allergists, Pulmonologists, Pediatricians, and Dermatologists.

• 2001 ranked in the top 10% of all the national Respiratory/Dermatology Sales Specialists for Combined Product Weighting • April 2002 Won Director’s Special Recognition Award “Elidel Impact Launcher Contest” Gold Level• March 2002 Won “Pot of Gold” growth contest with Pulmonologists and Allergists • January 2002 Placed Foradil on Ephrata Hospital’s formulary replacing Serevent• Ranked 8th out of 253 Specialists in the nation based on weighted product index• Ranked 3rd out of 56 Specialists in the region in the launch phase of a new respiratory product• Ranked 18th out of 256 Specialists in the nation in the launch phase of a new respiratory product• June & July 2001, Winner of the One 2 Watch Contest • 2001 Placed Foradil on Health Guard’s Tiered formulary book of business

2

Page 3: Matthew Stern MResume PA Nov-9-2015

Sales Consultant (6/98 to 3/01)Generates revenue from sales potential within territory. Develops customer relationships. Make presentations of Novartis products to targeted customers. Participates in training and development of new sales associates. Experienced in selling to Cardiologists and Nephrologists in and out of a hospital/cath-lab setting.

• 2000 Winner of East Area Regional Director Award• 1999 MVP Award winner; 1999 Diovan Summer Blitz Award Winner; 1999 Winner of Tri-State region Rapid Recognition Award• 1999 Ranked 5th CPI (Combined Product Index) out of 50 representatives; 1999 Ranked 8th in total commission dollars • 1999 Ranked in the top 2% of all Novartis Pharmaceutical representatives

Lamar Advertising Inc., Reading PA (11/96 to 06/98) Sales Manager – Managed 7 territory representatives with in the Northeast Region (12/97 to 06/98)Sales Representative (11/96 to 12/97)

Paychex Inc, Allentown PA (3/96 to 11/96) Sales Representative (3/96 to 11/96)

EDUCATIONCertified Healthcare Financial Professional Certification (2015)Certified Revenue Cycle Representative Certification (Anticipated November 2015)Member of HFMA (Healthcare Financial Management Association) (2015)PhD - Currently Enrolled in Doctoral Program in Business Administration (2016- Anticipated)M.B.A – Management / Marketing, LaSalle University, Philadelphia PA 3.56 GPA (2002)BA - Mass Communications, The Pennsylvania State University, State College, PA 3.01 GPA (1996)Selected to Cambridge “Who’s Who List” 2014 – 2007. Selected to The Global Directory of Who’s Who 2007

Alvernia University, Master of Business Administration Department Adjunct Professor, MBA program (04/03 to Present)

3